Vertex Pharmaceuticals Incorporated (VRTX)

264.33
4.00 1.50
NASDAQ
Prev Close 268.35
Open 265.51
Day Low/High 263.78 / 268.00
52 Wk Low/High 176.36 / 292.75
Volume 323.61K
Exchange NASDAQ
Shares Outstanding 255.76B
Market Cap 66.14B
P/E Ratio 23.27
Div & Yield N.A. (N.A)

Early-Morning Market Look

Let's start by taking a peek at the overnight and early-morning price action of the major asset classes. The rundown: S&P futures -4; Nasdaq futures -; Nikkei schmeissed for second day in a row, -3% and at the lowest level in three weeks (is Abe ret...

Vertex Pharmaceuticals downgraded at UBS

Is Stock Picking Impossible This Year?

Is Stock Picking Impossible This Year?

Stick with solid investing precepts.

Individuals Stand Strong

Individuals Stand Strong

We are seeing some hot pockets of momentum.

The Bears Get Fed

The Bears Get Fed

No setup for a bullish reaction to bullish news today.

A Market With No Memory

It can turn so quickly and totally forget poor action.

Feels Like a Bear Market

Feels Like a Bear Market

The best thing to do is get out of the way and let it play out.

The Action Has Shifted

The Action Has Shifted

And the close put an exclamation point on it.

Biotech's Next Big Thing: Vertex

Biotech's Next Big Thing: Vertex

TheStreet senior columnist Adam Feuerstein explains why Vertex Pharmaceuticals is the next big thing in biotech.

Still Plenty of Buying Interest

Still Plenty of Buying Interest

Action in individual stocks was impressive despite the struggling indices.

A One-Way Market

A One-Way Market

The action just keeps chugging higher.

Working for the Weekend

Working for the Weekend

I'm going to spend some time developing my watch list for next week.

Futures Point Higher; Boston Manhunt Plays Out

Futures Point Higher; Boston Manhunt Plays Out

US stock futures are up amid earnings from GE and IBM. TheStreet's Debra Borchardt details.

The Next Big Thing in Biotech: Earnings

The Next Big Thing in Biotech: Earnings

Adam Feuerstein, senior columnist for TheStreet, says biotech earnings are the next big thing to watch in biotech.

A Market in Limbo

A Market in Limbo

Traders are jockeying for position as we await the Fed, economic data and key earnings.

The Next Big Thing in Biotech: Dendreon/Vertex Earnings

The Next Big Thing in Biotech: Dendreon/Vertex Earnings

Senior columnist Adam Feuerstein says earnings from Dendreon and Vertex are the next big things in biotech.

The Next Big Thing In Biotech: Vertex

The Next Big Thing In Biotech: Vertex

Adam Feuerstein, Sr. Columnist for TheStreet, says Vertex Pharmaceuticals is the next big thing in biotech.